title: Will molecular diagnosis of drug-resistant tuberculosis improve patient outcomes?
authors.affiliation: Luthando Neuropsychiatric HIV Clinic, Chris Hani Baragwanath Academic Hospital, Soweto, South Africa.
authors.forename: Greg
authors.initials: G
authors.lastname: Jonsson
authors.forename: Jennifer
authors.initials: J
authors.lastname: Furin
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D003906:Developing Countries; D024901:Drug Resistance, Multiple, Bacterial; D005260:Female; D006297:Health Services Accessibility; D054625:Healthcare Disparities; D006801:Humans; D008826:Microbial Sensitivity Tests; D025202:Molecular Diagnostic Techniques; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification*; D011237:Predictive Value of Tests; D011787:Quality of Health Care; D013019:South Africa; D013997:Time Factors; D016896:Treatment Outcome; D018088:Tuberculosis, Multidrug-Resistant / Q000175:diagnosis* / Q000188:drug therapy* / Q000382:microbiology; D055815:Young Adult
chemical_list: D000995:Antitubercular Agents